EFNB1 and osteosarcoma: Based on the experimental observations by Yu, eprin-B1 enhances the Notch-driven osteosarcoma cells’ proliferation and chemoresistance, properties which were successfully reversed in ephrin-B1 knockdown in the aforementioned cells [17].